Recent developments in the immunopathology of COVID‐19

H Zhang, Y Sun, Y Wang, D Yazici, D Azkur, I Ogulur… - Allergy, 2023 - Wiley Online Library
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

Low cardiorespiratory fitness post-COVID-19: a narrative review

F Schwendinger, R Knaier, T Radtke… - Sports Medicine, 2023 - Springer
Patients recovering from COVID-19 often report symptoms of exhaustion, fatigue and
dyspnoea and present with exercise intolerance persisting for months post-infection …

[HTML][HTML] Protective effect of vitamin D supplementation on COVID-19-related intensive care hospitalization and mortality: definitive evidence from meta-analysis and …

C Argano, R Mallaci Bocchio, G Natoli, S Scibetta… - Pharmaceuticals, 2023 - mdpi.com
Pharmaceuticals | Free Full-Text | Protective Effect of Vitamin D Supplementation on COVID-19-Related
Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and …

Adenoviral vector-based vaccine platform for COVID-19: Current status

VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar… - Vaccines, 2023 - mdpi.com
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

A Aiello, S Najafi-Fard, D Goletti - Frontiers in Immunology, 2023 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …

The potential of probiotics as ingestible adjuvants and immune modulators for antiviral immunity and management of SARS-CoV-2 infection and COVID-19

S Tomkinson, C Triscott, E Schenk, A Foey - Pathogens, 2023 - mdpi.com
Probiotic bacteria are able to modulate general antiviral responsiveness, including barrier
functionality and innate and adaptive immune responses. The COVID-19 pandemic …

Long COVID: clinical framing, biomarkers, and therapeutic approaches

V Conti, G Corbi, F Sabbatino, D De Pascale… - Journal of Personalized …, 2023 - mdpi.com
More than two years after the onset of the COVID-19 pandemic, healthcare providers are
facing an emergency within an emergency, the so-called long COVID or post-COVID-19 …

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

KS Batista, JG de Albuquerque… - Nutrition research …, 2023 - cambridge.org
Scientists are working to identify prevention/treatment methods and clinical outcomes of
coronavirus disease 2019 (COVID-19). Nutritional status and diet have a major impact on …

COVID-19 Biogenesis and Intracellular Transport

AA Mironov, MA Savin, GV Beznoussenko - International journal of …, 2023 - mdpi.com
SARS-CoV-2 is responsible for the COVID-19 pandemic. The structure of SARS-CoV-2 and
most of its proteins of have been deciphered. SARS-CoV-2 enters cells through the …

COVID-19: diabetes perspective—pathophysiology and management

S Dallavalasa, SRV Tulimilli, J Prakash… - Pathogens, 2023 - mdpi.com
Recent evidence relating to the impact of COVID-19 on people with diabetes is limited but
continues to emerge. COVID-19 pneumonia is a newly identified illness spreading rapidly …